The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Ever Supreme Bio Technology posts record 81.85% third-quarter gross margin

Nov 5, 2026 04:15 (4h ago)

Verifying

Ever Supreme Bio Technology’s board approved its third-quarter financial report.
81.85% was the company’s record quarterly gross margin.
Third-quarter consolidated revenue was NT$321 million, according to the company.